106 related articles for article (PubMed ID: 26125767)
1. Disease indicators for sepsis and analysis of sepsis treatment in children using the continuous blood purification technique.
Liu JP; Wang XW; Qie LP
Genet Mol Res; 2015 May; 14(2):5685-93. PubMed ID: 26125767
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
Pei Q; Sang WF; Zhao XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency.
Andreassen M; Vestergaard H; Kristensen LØ
Clin Endocrinol (Oxf); 2007 Dec; 67(6):909-16. PubMed ID: 17727678
[TBL] [Abstract][Full Text] [Related]
5. IL-6, but not TNF-α, increases plasma YKL-40 in human subjects.
Nielsen AR; Plomgaard P; Krabbe KS; Johansen JS; Pedersen BK
Cytokine; 2011 Jul; 55(1):152-5. PubMed ID: 21478032
[TBL] [Abstract][Full Text] [Related]
6. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
7. Continuous blood purification in children with severe sepsis.
Guo XH; Sun YF; Han SZ; Miao J; Cui M; Wang JB
J Biol Regul Homeost Agents; 2017; 31(2):389-394. PubMed ID: 28685542
[TBL] [Abstract][Full Text] [Related]
8. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
[TBL] [Abstract][Full Text] [Related]
9. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between expression of microRNA and inflammatory cytokines plasma level in pediatric patients with sepsis].
Wu Y; Li C; He Y; Li Q; Wang G; Wen P; Yang W; Yang Y
Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):28-33. PubMed ID: 24680405
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C
Regul Pept; 2013 May; 183():69-73. PubMed ID: 23501042
[TBL] [Abstract][Full Text] [Related]
12. Serum YKL-40 is increased in patients with slow coronary flow.
Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40.
Aziz M; Wissing ML; Naver KV; Faber J; Skouby SO
Gynecol Endocrinol; 2014 Apr; 30(4):311-5. PubMed ID: 24471491
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of interleukin-1 alpha, interleukin-6 and tumor necrosis factor-alpha in neonatal sepsis and meningitis.
Fida NM; Al-Mughales JA; Fadelallah MF
Saudi Med J; 2006 Oct; 27(10):1508-14. PubMed ID: 17013473
[TBL] [Abstract][Full Text] [Related]
15. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
16. [Continuous blood purification therapy in 22 children with sepsis].
Lu GP; Lu ZJ; Zhang LE; He J; Hu J; Wu F
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):573-8. PubMed ID: 17083779
[TBL] [Abstract][Full Text] [Related]
17. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
[TBL] [Abstract][Full Text] [Related]
18. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome.
Li W; Yu Z; Jiang C
Lab Med; 2014; 45(3):220-5. PubMed ID: 25051073
[TBL] [Abstract][Full Text] [Related]
19. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
[TBL] [Abstract][Full Text] [Related]
20. Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
Keles ZP; Keles GC; Avci B; Cetinkaya BO; Emingil G
J Periodontol; 2014 Sep; 85(9):1240-6. PubMed ID: 24635545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
